Astellas Pharma Inc. (TYO:4503)

Astellas Pharma Revenue

Astellas Pharma had revenue of 524.32B JPY in the quarter ending September 30, 2025, with 13.37% growth. This brings the company's revenue in the last twelve months to 2.01T, up 13.24% year-over-year. In the fiscal year ending March 31, 2025, Astellas Pharma had annual revenue of 1.91T with 19.25% growth.

• Revenue (ttm): 2.01T
• Revenue Growth: +13.24%
• P/S Ratio: 1.69
• Revenue / Employee: 147.09M
• Employees: 13,643
• Market Cap: 3.39T

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	1.91T	308.65B	19.25%
Mar 31, 2024	1.60T	85.05B	5.60%
Mar 31, 2023	1.52T	222.46B	17.16%
Mar 31, 2022	1.30T	46.64B	3.73%
Mar 31, 2021	1.25T	-51.32B	-3.94%